CombinatoRx, Incorporated (CRXX) is pioneering the new field of synergistic combination pharmaceuticals and has a broad product portfolio in phase 2 clinical development. Going beyond traditional combinations, CombinatoRx creates product candidates with novel mechanisms of action striking at the biological complexities of human disease. The lead programs in the CombinatoRx portfolio are advancing into later stage clinical trials based on the strength of multiple positive Phase 2a results. This portfolio is internally generated from the CombinatoRx proprietary drug discovery technology which provides a renewable and previously untapped source of novel drug candidates. The Company was founded in 2000 and is located in Cambridge, Massachusetts.
| Website | http://www.combinatorx.com |
| Revenue | $23.1 million |
| Employees | View employees |
| Address | 650 Albany St, Boston, Massachusetts 02118, US |
| Phone | +1 617-425-7000 |
| Industry | Internet Service Providers, Website Hosting & Internet-Related Services, Telecommunications |
| Competitors | The Janssen Pharmaceutical Companies of Johnson & Johnson, Merck & Co., Inc., Pfizer, Amgen, Regeneron, Gilead Sciences, Vertex Pharmaceuticals, Biogen, Receptos, a wholly-owned subsidiary of Celgene, Lilly India +37 more (view full list) |
| SIC | SIC Code 206 Companies, SIC Code 20 Companies |
| NAICS | NAICS Code 3113 Companies, NAICS Code 31131 Companies, NAICS Code 311 Companies, NAICS Code 31 Companies, NAICS Code 311314 Companies |
Looking for a particular CombinatoRx , Incorporated employee's phone or email?
CombinatoRx , Incorporated Questions
The CombinatoRx , Incorporated annual revenue was $23.1 million in 2026.
CombinatoRx , Incorporated is based in Boston, Massachusetts.
The NAICS codes for CombinatoRx , Incorporated are [3113, 31131, 311, 31, 311314].
The SIC codes for CombinatoRx , Incorporated are [206, 20].
